Maintaining the polyclonal nature of the resistant population, we first engineered HCC827-OsiR cells to stably express Cas9, which was functionally validated by targeting the pan-cancer essential gene RPA3 (Supplementary Fig. 7c, d). Here, RPA3 is linked to cancer.